Interestingly, molecular subtypes of CTNNB1 or specific gene expression signatures are emerging as biomarkers for recurrence risk.[6–9,36–38] We have summarized previous studies on the putative molecular biomarkers for desmoid tumors in Table 2. The gene discussed is CTNNB1; the disease is desmoid tumor.